Label at a glance#

ProductDPC Noblesse Suta Eye

Active ingredientADENOSINE, NIACINAMIDE

Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Niacinamide, Adenosine

INACTIVE INGREDIENT SECTION

Water
Glycerin
Butylene Glycol
Hydrogenated Polydecene
Cyclopentasiloxane
Cyclohexasiloxane
1,2-Hexanediol
Butyrospermum Parkii (Shea) Butter
Dimethicone
Polysorbate 60
Hydrogenated Polyisobutene
Jojoba Esters
Polyacrylate-13
Cetearyl Olivate
Sorbitan Olivate
Cetearyl Alcohol
Cetearyl Glucoside
Cetyl Alcohol
Glyceryl Stearate
Phytosteryl/Isostearyl/Cetyl/Stearyl/Behenyl Dimer Dilinoleate
Polyisobutene
Caprylyl Glycol
Phenoxyethanol
Sodium Polyacrylate
Dimethicone Crosspolymer
Fragrance(Parfum)
Polysorbate 20
Sorbitan Isostearate
Dipotassium Glycyrrhizate
Ethylhexylglycerin
Disodium EDTA
Hydroxypropyl Starch Phosphate
Coccinia Indica Fruit Extract
Eclipta Prostrata Extract
Dextrin
Theobroma Cacao (Cocoa) Extract
Propanediol
Euterpe Oleracea Fruit Extract
Hippophae Rhamnoides Fruit Extract
Rubus Idaeus (Raspberry) Fruit Extract
Dipeptide Diaminobutyroyl Benzylamide Diacetate
Tocopherol
Anemarrhena Asphodeloides Root Extract
Croton Lechleri Resin Extract
Combretum Farinosum Flower Nectar
Acetyl Hexapeptide-8

OTC - PURPOSE SECTION

Skin Protectant - Whitening & Anti-wrinkle

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

Apply a proper amount on the skin and spread evenly.

WARNINGS SECTION

For external use only.
Avoid contact with eyes. Not for human consumption.
Discontinue use if irritation occurs.
If irritation persists, consult a physician.

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ADENOSINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d676a241-be05-4740-b3ee-1a5f2ed422d2	Product name	4	20180615
dd8bd48f-20d6-43c7-b471-3ae872868afa	Product name	3	20180125
d41954ff-bc63-4b2c-aba0-9146707659d7	Product name	2	20151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71673-0004-1	2020-01-31	C162847	48780-1	9d75b9d0-08ef-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71673-0004-1	DPC Noblesse Suta Eye	20 mL in 1 TUBE	CREAM	20		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71673-0004	DPC NOBLESSE SUTA EYE (NIACINAMIDE, ADENOSINE) CREAM [MSCO]	1	Legacy NDC, 1 package rows	20170818_5700e699-878c-03ed-e054-00144ff8d46c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

DPC Noblesse Suta Eye
NIACINAMIDE, ADENOSINE
ADENOSINE
WATER
GLYCERIN
NIACINAMIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
71673-0004	71673-0004-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ADENOSINE	K72T3FS567	ACTIB
WATER	059QF0KO0R	IACT
GLYCERIN	PDC6A3C0OX	IACT
NIACINAMIDE	25X51I8RD4	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
57002112-3182-496e-e054-00144ff88e88			5700e699-878c-03ed-e054-00144ff8d46c	2017-08-18	Warnings	Exact identifier spl id: 57002112-3182-496e-e054-00144ff88e88 spl set id: 5700e699-878c-03ed-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.